Renergen Limited and DPD Laser (Limited) have entered into an agreement for the manufacture and purchase of the first 110 Cryo-VaccTM cases, following the launch of Renergen's Cryo-VaccTM storage solution. The key terms of the agreement with DPD Laser are: The agreement relates to a fixed purchase of 110 Cryo-VaccTM cases in a combination of all three sizes; and The Cryo-VaccTM cases will be delivered in May. There are no other material conditions to the agreement. Whilst the agreement with DPD Laser is not considered material to the Company from a revenue perspective, it represents a significant milestone for the Company regarding the commencement of manufacturing of the Cryo-VaccTM to its customers. The agreement has been completed ahead of the launch of Phase 2 vaccination program for SA. Renergen has commenced construction of the 110 Cryo-VaccTM cases for delivery to DPD Laser, which is expected to be completed by the end of May 2021. DPD Laser will offer the Cryo-VaccTM cases to the market on a monthly rental arrangement, including the maintenance, delivery, and collection of the Cryo-VaccTM cases from respective maintenance points. The three sizes offered currently include a large case (up to 2,400 vials), a medium case (up to 1,200 vials and a smaller case (up to 240 vials) which is ideal for smaller vaccination points such as pharmacies and medical practices.